These experiments demonstrated that the berberine-As2O3-mediated enhanced suppression of ERK phosphorylation led to a decrease of the levels of ODC, MT1-MMP, and MMP-2 in C6 glioma cells to values that resembled those observed in negative controls (Figure 7A). The gene discussed is MMP2; the disease is central nervous system cancer.